Memantine in treatment of OCD
Phase 2
- Conditions
- Obsessive-Compulsive Disorder.Obsessive-compulsive disorder
- Registration Number
- IRCT20211118053093N5
- Lead Sponsor
- Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
OCD diagnosis based on DSM-V criteria
Y-BOCS score equal or more than 18
Exclusion Criteria
Drug abuse
Pregnancy
Medical problems
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Yale-Brown Obsessive Compulsive Scale score. Timepoint: Week 0, 4, 8 ,12, and 16. Method of measurement: Yale-Brown Obsessive Compulsive Scale questionnaire.;Barkley Deficits in Executive Functioning Scale score. Timepoint: Week 0 and 16. Method of measurement: Barkley Deficits in Executive Functioning Scale questionnaire.
- Secondary Outcome Measures
Name Time Method